JZD-07

• UNSPSC Description:

  JZD-07 is a potent SARS-CoV 3CLpro inhibitor. JZD-07 can be used in the study of SARS-CoV-2 infection[1].

• Target Antigen:

  SARS-CoV

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/jzd-07.html

• Smiles:

  O=C1C=C(C2=C(N1)C=CC=C2)C(N3CCN(CC3CN4CCOCC4)C5=CC=C(C(Cl)=C5)Cl)=O

• Molecular Weight:

  501.40

• References & Citations:

  [1]Jiang Z, et al. Discovery of Novel Nonpeptidic and Noncovalent Small Molecule 3CLpro Inhibitors as anti-SARS-CoV-2 Drug Candidate. J Med Chem. 2024 Aug 8;67(15):12760-12783.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2917528-98-2